Navigation Links
Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Apr 30, 2007 - Amgen (NASDAQ:AMGN), today announced final results from a pivotal Phase 3 trial which showed that Vectibix(TM) (panitumumab), a fully human monoclonal antibody directed against the epidermal growth factor receptor (EGFr), prolonged progression-free survival (PFS) compared to best supportive care (BSC) in metastatic colorectal cancer patients who had failed fluoropyrimidine, irinotecan, and oxaliplatin containing chemotherapy regimens. The results were published in the May issue of the Journal of Clinical Oncology.

"Medical advances in the treatment of first- and second-line colorectal cancer have improved survival rates; however, most patients develop resistance to these therapies, creating the need for an active agent to treat patients with advanced disease," said Professor Eric Van Cutsem, M.D., Ph.D., Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium, lead author of the manuscript. "Final results from the first large randomized trial of its kind show that Vectibix provides a benefit in this heavily pre-treated patient population."

The September 2006 Food and Drug Administration (FDA) approval of Vectibix was based on the results from this multi-national, open-label, randomized study of 463 patients. Patients were randomized to receive 6 mg/kg Vectibix plus BSC (n=231) every two weeks or BSC alone (n=232) until disease progression or unacceptable toxicity. An independent, central radiology review board assessed disease progression and tumor shrinkage. BSC patients determined to have disease progression were eligible to cross-over to a separate study and receive Vectibix.

The primary endpoint of this study was an improvement in progression-free survival. Co-secondary study endpoints were best objective response by blinded central review and overall survival time. The effectiveness of Vectibix for the treatment of EGFr
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
2. Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
3. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
4. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
5. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
6. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:9/16/2014)... 17 settembre 2014 Hologic, Inc. (NASDAQ: ... lancio in Europa del Tomcat, un nuovo strumento ... piattaforma multifunzionale completamente automatizzata, progettata per semplificare la ... i rischi di errore legati alla gestione manuale ... Tomcat di Hologic riduce il carico di lavoro ...
(Date:9/16/2014)... September 2014 Hologic, Inc. ... heute die Markteinführung des Tomcat, einem ... Europa bekannt gegeben. Der Tomcat ist ... Vereinfachung der präanalytischen Probenverarbeitung. Dies wird ... Arbeitsschritte bei der manuellen Aliquotierung von ...
(Date:9/16/2014)... YORK , Sept. 16, 2014 This report ... US$ Million by the following Product Segments: SPECT Systems (Includes ... PET/CT systems). The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... World. Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 3Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 3Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26
(Date:9/16/2014)... FL (PRWEB) September 17, 2014 Retinol is ... especially for anti-aging care. , "Retinol has so many benefits ... health," says Kathy Heshelow, founder of Sublime Beauty . ... part in it." , The Sublime Beauty® Retinol Serum with ... top ingredients for skin care. The Retinol Serum ...
(Date:9/16/2014)... UWDress.com, the well-known wedding dress manufacturer and retailer, has ... online. Additionally, the firm has launched a promotion for ... now, up to 62 percent off. , ... has won a lot of positive reviews for its ... providing big savings on many other items, including corset ...
(Date:9/16/2014)... 2014 Pulmonary Hypertension Association Travels to San ... for PH Patients and Families to Help Fight Rare Lung ... country’s leading pulmonary hypertension association that works to find ways ... of the lungs that affects the functioning of the heart ... survivability is only 2.8 years. , What:, PHA ...
(Date:9/16/2014)... 2014 Paradigm Physical Therapy is proud ... therapeutic treatment for their patients. Dry needling is a ... variety of musculoskeletal problems. , In this invasive procedure, ... the skin and muscle to create a trigger point. ... needle helps to deactivate and release the trigger point ...
(Date:9/16/2014)... monitors hold great promise in helping people to ... sophisticated devices help the wearers improve their wellness ... This information is organized into companion computer programs ... and quickly growing market for these devices, researchers ... Galveston analyzed 13 of these activity monitors, such ...
Breaking Medicine News(10 mins):Health News:Retinol, the Gold Standard in Skin Care, Available in a Serum with Vitamin C from Sublime Beauty®; Now 30% Off 2Health News:New Elegant Evening Wear Assortment Released By UWDress.com 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:Do wearable lifestyle activity monitors really work? 2Health News:Do wearable lifestyle activity monitors really work? 3
... ... Club, the Endangered Habitats League and SOS Hills will honor "Avatar" ... Outstanding Social Responsibility in Media. "Avatar,s" themes closely mirror the ... residents are facing against Granite Construction, a powerful corporation that wants ...
... New York personal injury lawyers ... are safe, no matter how the economy has affected them. , ... New York, NY (PRWEB) March 3, 2010 -- According to yesterday’s ... apart. New York personal injury lawyers , familiar with the situation, point to a decline ...
... ... ... ... ...
... ... ... , ... , ...
... ANN ARBOR, Mich. Freezing a cancer kills it in ... that helps stop the cancer,s spread, leading to improved survival ... from researchers at the University of Michigan Comprehensive Cancer Center. ... involve applying a cold probe to a tumor to freeze ...
... of scientists studying acute forms of Leukaemia have identified a ... for the growth of diseased cells. The research, reported in ... ,addicted, to genes, which if targeted could prevent diseased cells ... from the University of Vienna, carried out their research on ...
Cached Medicine News:Health News:Temecula Environmental Groups & City to Honor "Avatar" Director James Cameron with First Ever Environmental Media Award 2Health News:Temecula Environmental Groups & City to Honor "Avatar" Director James Cameron with First Ever Environmental Media Award 3Health News:Temecula Environmental Groups & City to Honor "Avatar" Director James Cameron with First Ever Environmental Media Award 4Health News:A Warning to Negligent Apartment Building Landlords in New York From Personal Injury Lawyer, David Perecman 2Health News:A Warning to Negligent Apartment Building Landlords in New York From Personal Injury Lawyer, David Perecman 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 2Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 3Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 4Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 5Health News:AUA Responds to American Cancer Society Guideline for the Early Detection of Prostate Cancer 6Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 2Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 3Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 4Health News:Vermillion Announces the Appointment of Carl Severinghaus to Board of Directors 5Health News:Freezing breast tumors helps stop cancer’s spread in mice, U-M study finds 2Health News:Targeting leukemia cell's gene 'addiction' presents new strategy for treatment 2
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
Medicine Products: